GO:0034477 U6 snRNA 3'-end processing: RNA Maturation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034477 describes any process that forms the mature 3' end of a U6 snRNA molecule, a non-coding RNA essential for pre-mRNA splicing.
• U6 snRNA 3'-end processing involves exonucleolytic trimming, terminal uridylation, and 2',3'-cyclic phosphate formation, generating a mature end that is specifically recognized by the U6 snRNP [1, 5, 8].
• Key enzymes include TUT1 (terminal uridylyltransferase 1), which adds a short oligo(U) tail to U6 snRNA [2, 7], and C16orf57 (USB1), a phosphodiesterase that removes the 3'-terminal uridine to expose a 2',3'-cyclic phosphate.
• Disruption of U6 snRNA 3'-end processing impairs spliceosome assembly and function, affecting pre-mRNA splicing and gene expression [1, 5].
• Mutations in USB1 (C16orf57) cause poikiloderma with neutropenia, a rare genetic disorder, linking U6 3'-end processing to human disease.
• In plants, the U6 Biogenesis-Like 1 (UBL1) protein is critical for U6 snRNA 3'-end processing and affects kernel and seedling development in maize.
Description
U6 snRNA is a highly conserved non-coding RNA that forms the catalytic core of the spliceosome, the macromolecular machine responsible for removing introns from pre-mRNA. For U6 snRNA to function, its 3' end must be precisely processed to generate a mature terminus that is recognized by specific proteins and incorporated into the U6 snRNP. The Gene Ontology term GO:0034477, U6 snRNA 3'-end processing, encompasses all molecular events that convert the primary U6 snRNA transcript into its mature 3' end form [1, 5]. This process is essential for spliceosome assembly and catalytic activity, and defects in it can lead to widespread splicing defects and disease. Researchers study U6 snRNA 3'-end processing to understand fundamental RNA maturation mechanisms, spliceosome dynamics, and the molecular basis of diseases such as poikiloderma with neutropenia. The pathway involves a series of enzymatic steps, including exonucleolytic trimming, uridylation by TUT1, and phosphodiesterase-mediated removal of a terminal uridine to generate a 2',3'-cyclic phosphate [2, 6, 8]. These modifications are critical for the specific recognition of U6 snRNA by the U6 snRNP protein Prp24 (in yeast) or its human counterpart, ensuring proper spliceosome function. Given its central role in gene expression, U6 snRNA 3'-end processing is a focal point for understanding RNA biology and developing therapeutic strategies for splicing-related diseases.
U6 snRNA 3'-end processing At A Glance
| GO ID | GO:0034477 |
|---|---|
| GO term | U6 snRNA 3'-end processing |
| Ontology | biological_process |
| Synonym | U6 snRNA 3' end processing |
| Major function | Maturation of the 3' end of U6 snRNA, enabling its incorporation into the spliceosome |
| Key enzymes | TUT1 (terminal uridylyltransferase 1), USB1/C16orf57 (phosphodiesterase), exonucleases |
| Key modifications | Oligouridylation, 2',3'-cyclic phosphate formation, exonucleolytic trimming |
| Cellular context | Nucleus, spliceosome assembly |
| Related disease | Poikiloderma with neutropenia (USB1 mutations) |
What Is GO:0034477?
GO:0034477, U6 snRNA 3'-end processing, is defined as any process involved in forming the mature 3' end of a U6 snRNA molecule. This includes the enzymatic steps that trim, modify, and finalize the 3' terminus of U6 snRNA, such as exonucleolytic cleavage, terminal uridylation, and the formation of a 2',3'-cyclic phosphate [1, 5, 8]. The term captures the maturation events that convert a precursor U6 snRNA into a functional form capable of being assembled into the U6 snRNP and participating in pre-mRNA splicing.
Why Is U6 snRNA 3'-end processing Important in Cell Biology?
U6 snRNA 3'-end processing is essential for the biogenesis of a functional spliceosome, the machinery that catalyzes pre-mRNA splicing in all eukaryotes. Without proper 3'-end maturation, U6 snRNA cannot be efficiently incorporated into the U6 snRNP, leading to defective spliceosome assembly and widespread splicing defects [1, 5]. This process is also critical for regulating the levels of mature U6 snRNA and ensuring its stability [2, 7]. In humans, mutations in USB1, the enzyme responsible for the final step of U6 3'-end processing, cause poikiloderma with neutropenia, a rare autosomal recessive disorder characterized by skin abnormalities and immune dysfunction. In plants, disruption of U6 3'-end processing affects development, as seen in maize UBL1 mutants. Thus, understanding U6 snRNA 3'-end processing provides insights into fundamental RNA biology, spliceosome function, and human disease mechanisms.
• Required for spliceosome assembly and pre-mRNA splicing.
• Ensures U6 snRNA stability and correct 3' end structure [2, 7].
• Mutations in USB1 cause poikiloderma with neutropenia.
• Defects lead to global splicing abnormalities.
• Conserved from yeast to humans, with plant homologs affecting development.
• Involves terminal uridylation by TUT1, a key regulatory step [2, 7].
• Generates a 2',3'-cyclic phosphate essential for U6 snRNP recognition [1, 8].
• Potential target for therapeutic intervention in splicing-related diseases.
• Provides a model for studying RNA 3' end processing mechanisms.
• Links RNA modification enzymes to developmental and immune disorders.
What Happens During U6 snRNA 3'-end processing?
Exonucleolytic trimming of the U6 snRNA 3' end
In simple terms: The initial U6 snRNA transcript has extra nucleotides at its 3' end that must be trimmed off.
After transcription, the 3' end of U6 snRNA undergoes exonucleolytic trimming to remove extra nucleotides, generating a precursor that can be further modified [1, 5]. This step is thought to involve unidentified exonucleases that shorten the 3' extension, preparing the RNA for terminal uridylation. The trimming process is essential for producing a substrate that can be recognized by TUT1 and other processing factors.
Terminal uridylation by TUT1
In simple terms: An enzyme called TUT1 adds a short string of uridines to the 3' end of U6 snRNA.
TUT1 (terminal uridylyltransferase 1) catalyzes the addition of a short oligo(U) tail to the 3' end of U6 snRNA [2, 7]. This uridylation is a key modification that marks the RNA for subsequent processing steps. Structural and biochemical studies have revealed the mechanism by which human TUT1 recognizes U6 snRNA and adds uridines, providing insights into its specificity. The oligo(U) tail is later removed or modified to generate the mature 3' end.
Formation of 2',3'-cyclic phosphate by USB1
In simple terms: The enzyme USB1 trims off the last uridine and leaves a special cyclic phosphate group at the 3' end.
USB1 (also known as C16orf57) is a phosphodiesterase that removes the 3'-terminal uridine from U6 snRNA, generating a 2',3'-cyclic phosphate at the mature 3' end. This modification is critical for the specific recognition of U6 snRNA by the U6 snRNP protein Prp24 (yeast) or its human homolog. Mutations in USB1 cause poikiloderma with neutropenia, highlighting the importance of this step. The 2',3'-cyclic phosphate is a unique feature of mature U6 snRNA and is required for its function in splicing.
Recognition and assembly into the U6 snRNP
In simple terms: The processed U6 snRNA is recognized by specific proteins and assembled into the spliceosome.
After 3'-end processing, the mature U6 snRNA is bound by the U6 snRNP-specific protein Prp24 (in yeast) or its human counterpart, which recognizes the 2',3'-cyclic phosphate and the oligo(U) tail. This assembly is essential for the incorporation of U6 snRNA into the spliceosome. The architecture of the U6 snRNP reveals specific recognition of the processed 3' end, ensuring that only correctly matured U6 snRNA is used for splicing. Defects in this recognition step impair spliceosome assembly and splicing.
Key Genes Involved in GO:0034477 U6 snRNA 3'-end processing
The following genes and proteins are experimentally implicated in U6 snRNA 3'-end processing, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TUT1 | Terminal uridylyltransferase that adds oligo(U) tail to U6 snRNA | Key enzyme for U6 3' end modification; target for studying uridylation mechanisms [2, 7] |
| USB1 (C16orf57) | Phosphodiesterase that removes terminal uridine to form 2',3'-cyclic phosphate | Mutations cause poikiloderma with neutropenia; critical for U6 maturation |
| PRP24 (yeast) | U6 snRNP protein that recognizes processed 3' end | Model for studying U6 snRNP assembly and 3' end recognition |
| LSm proteins | Bind U6 snRNA and facilitate its incorporation into snRNP | Involved in U6 snRNP stability and function |
| UBL1 (maize) | U6 biogenesis-like 1, affects U6 snRNA 3' end processing | Plant model for U6 processing and development |
| TUT4/7 | Related terminal uridylyltransferases | May have overlapping or distinct roles in U6 modification |
| Exonucleases (unidentified) | Trim 3' extension of U6 snRNA | Potential targets for understanding initial processing steps |
| Prp8 | Spliceosomal protein interacting with U6 snRNA | Links U6 processing to spliceosome function |
| Snu114 | GTPase involved in spliceosome dynamics | May influence U6 snRNP assembly |
| Prp19 complex | Spliceosome activation | Downstream of U6 processing |
| Cwc2 | U6 snRNA-binding protein | Involved in spliceosome assembly |
| Brr2 | RNA helicase that unwinds U6 snRNA | Regulates U6 snRNA conformation |
| Prp3 | U4/U6 snRNP protein | Stabilizes U6 snRNA in the tri-snRNP |
| Prp31 | U4/U6 snRNP protein | Required for U6 snRNP assembly |
| SART1 | U4/U6 snRNP protein | Involved in tri-snRNP formation |
| Prp6 | Tri-snRNP protein | Links U6 processing to spliceosome assembly |
| Prp28 | Tri-snRNP protein | Facilitates U4/U6 unwinding |
| U6 snRNA itself | Non-coding RNA component of spliceosome | Central substrate of the processing pathway [1, 5] |
How Is U6 snRNA 3'-end processing Regulated?
The regulation of U6 snRNA 3'-end processing is not fully understood, but evidence suggests that the levels and activity of TUT1 and USB1 are critical determinants [2, 6]. TUT1-mediated uridylation is a regulated step that can influence U6 snRNA maturation and stability [2, 7]. Additionally, the recognition of the processed 3' end by U6 snRNP proteins provides a quality control mechanism that ensures only correctly matured U6 snRNA is incorporated into the spliceosome. In plants, UBL1 is essential for U6 3' end processing and its expression affects development, indicating developmental regulation. Further studies are needed to elucidate the signaling pathways that control these enzymes.
U6 snRNA 3'-end processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USB1 (C16orf57) | Poikiloderma with neutropenia | Knockout or point-mutation in human cell lines; patient-derived fibroblasts |
| TUT1 | Not directly linked to a disease, but involved in U6 modification | Knockout in cell lines to study U6 processing defects [2, 7] |
| UBL1 (maize) | Kernel and seedling developmental defects | Maize ubl1 mutants |
| PRP24 (yeast) | Splicing defects | Yeast prp24 mutants |
| U6 snRNA | Splicing-related disorders | Mutagenesis of U6 snRNA 3' end in cell lines |
Poikiloderma with neutropenia
Mutations in USB1 (C16orf57), the phosphodiesterase responsible for the final step of U6 snRNA 3'-end processing, cause poikiloderma with neutropenia, a rare autosomal recessive disorder characterized by skin abnormalities, neutropenia, and increased susceptibility to infections. This link underscores the importance of U6 3'-end processing in human health and immune function.
Splicing-related disorders
Defects in U6 snRNA 3'-end processing can lead to impaired spliceosome assembly and widespread splicing defects, which are associated with various diseases including cancer and neurodegenerative disorders [1, 5]. However, direct links to specific diseases beyond poikiloderma with neutropenia require further investigation.
Developmental defects in plants
In maize, mutations in UBL1, which affects U6 snRNA 3' end processing, cause defects in kernel and seedling development, demonstrating the importance of this pathway in plant growth and development.
From U6 snRNA 3'-end processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of TUT1 in U6 snRNA 3'-end processing? | TUT1 knockout cell lines (e.g., HEK293) |
| How does USB1 mutation affect U6 snRNA maturation? | USB1 point-mutation knock-in cell lines |
| What is the impact of U6 3' end modifications on spliceosome assembly? | Tagged knock-in of U6 snRNA with affinity tags |
| Can overexpression of TUT1 rescue U6 processing defects? | Overexpression of TUT1 in USB1 mutant cells [2, 6] |
| What are the developmental consequences of U6 processing defects in plants? | Maize ubl1 mutants |
| How does the 2',3'-cyclic phosphate affect U6 snRNP recognition? | In vitro binding assays with mutant U6 snRNA [1, 8] |
How to Study the U6 snRNA 3'-end processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression and splicing patterns | Assessing splicing defects upon U6 processing disruption |
| 3' RACE | 3' terminal sequence of U6 snRNA | Determining oligo(U) tail length and cyclic phosphate |
| Mass spectrometry | Protein interactions with U6 snRNA | Identifying U6 snRNP components |
| In vitro uridylation assay | TUT1 enzymatic activity | Mechanistic studies of U6 modification |
| Phosphodiesterase assay | USB1 activity | Measuring 2',3'-cyclic phosphate formation |
| CRISPR knockout screen | Genes required for U6 processing | Discovery of novel processing factors |
| Northern blot | U6 snRNA size and abundance | Detecting processing intermediates |
| EMSA | Protein-RNA binding affinity | Studying U6 snRNP assembly |
RNA sequencing and 3' end mapping
RNA-seq and specialized 3' end mapping techniques (e.g., circularization for 3' end sequencing) can determine the precise 3' terminal nucleotides of U6 snRNA and assess processing efficiency [1, 5]. These methods are used to quantify oligo(U) tail length and the presence of 2',3'-cyclic phosphate.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins associated with U6 snRNA during processing, such as TUT1, USB1, and U6 snRNP components [1, 2]. This approach helps define the processing machinery and its dynamics.
In vitro processing assays
Reconstituted in vitro systems using recombinant TUT1 and USB1 can dissect the enzymatic steps of U6 3' end processing, including uridylation and phosphodiesterase activity [2, 6, 8]. These assays allow precise kinetic and mechanistic studies.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for U6 snRNA 3' end processing by selecting for cells with defective splicing or altered U6 maturation. Such screens can uncover novel factors and pathways.
How CRISPR Can Be Used to Study GO:0034477 U6 snRNA 3'-end processing
Knockout
CRISPR knockout of TUT1 or USB1 in human cell lines can abolish U6 snRNA 3' end processing, leading to accumulation of unprocessed U6 and splicing defects [2, 6]. These models are valuable for studying the consequences of processing loss and for identifying compensatory pathways.
Point Mutation
Introducing disease-associated point mutations in USB1 (e.g., those found in poikiloderma with neutropenia) via CRISPR knock-in allows researchers to study the molecular basis of the disease and test potential therapies. Point mutations in TUT1 can also dissect its catalytic mechanism.
Knock-in
Tagged knock-in of U6 snRNA or its processing enzymes (e.g., GFP-TUT1) enables live-cell imaging and affinity purification to track processing dynamics and interactions. Knock-in of mutant U6 snRNA with altered 3' ends can reveal the importance of specific modifications.
Overexpression
Overexpression of TUT1 or USB1 can rescue processing defects in mutant cells or amplify the pathway for biochemical studies [2, 6]. Conversely, overexpression of dominant-negative mutants can inhibit processing and reveal its role in splicing.
How EDITGENE Supports U6 snRNA 3'-end processing Research
Researchers studying U6 snRNA 3'-end processing-related genes often need to determine whether a candidate gene is causally involved in the pathway, and CRISPR-based models are essential for such functional validation. EDITGENE provides comprehensive services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, to accelerate discoveries in RNA processing and spliceosome biology.
Contact EDITGENE today to design your custom CRISPR model for U6 snRNA 3'-end processing research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| USB1 Knockout HEK293 Cell Line | EDJ-KQ16047 | Human | 79650 | Details Get a Quote |
| USB1 Knockout A-549 Cell Line | EDJ-KQ47170 | Human | 79650 | Details Get a Quote |
| USB1 Knockout HCT 116 Cell Line | EDJ-KQ47171 | Human | 79650 | Details Get a Quote |
| USB1 Knockout HeLa Cell Line | EDJ-KQ47172 | Human | 79650 | Details Get a Quote |
| Tut1 Knockout 3T3-L1 Cell Line | EDJ-KZ70 | Mouse | 70044 | Details Get a Quote |
Frequently Asked Questions About U6 snRNA 3'-end processing
What is U6 snRNA 3'-end processing?
U6 snRNA 3'-end processing (GO:0034477) is the set of molecular events that form the mature 3' end of U6 snRNA, including exonucleolytic trimming, terminal uridylation, and 2',3'-cyclic phosphate formation [1, 5, 8].
What genes are involved in U6 snRNA 3'-end processing?
Key genes include TUT1, which adds an oligo(U) tail, and USB1 (C16orf57), which removes the terminal uridine to form a 2',3'-cyclic phosphate [2, 6].
Why is U6 snRNA 3'-end processing important?
It is essential for U6 snRNP assembly and spliceosome function; defects lead to splicing abnormalities and diseases such as poikiloderma with neutropenia [1, 6].
What diseases are linked to U6 snRNA 3'-end processing?
Mutations in USB1 cause poikiloderma with neutropenia, a rare disorder with skin and immune defects.
How is U6 snRNA 3'-end processing studied?
Common methods include RNA-seq, 3' RACE, in vitro enzymatic assays, and CRISPR screens [2, 5, 6].
What is the role of TUT1 in U6 snRNA processing?
TUT1 is a terminal uridylyltransferase that adds a short oligo(U) tail to U6 snRNA, a critical modification for subsequent processing [2, 7].
What is the role of USB1 in U6 snRNA processing?
USB1 is a phosphodiesterase that removes the 3'-terminal uridine from U6 snRNA, generating a 2',3'-cyclic phosphate essential for U6 snRNP recognition.
Can CRISPR be used to study U6 snRNA 3'-end processing?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect the pathway and model diseases.
What is the 2',3'-cyclic phosphate in U6 snRNA?
It is a unique modification at the mature 3' end of U6 snRNA, required for specific recognition by U6 snRNP proteins [1, 8].
Is U6 snRNA 3'-end processing conserved in plants?
Yes, the U6 Biogenesis-Like 1 (UBL1) protein in maize is important for U6 snRNA 3' end processing and affects development.
Conclusion
U6 snRNA 3'-end processing (GO:0034477) is a fundamental RNA maturation pathway that ensures the production of a functional U6 snRNA for spliceosome assembly and pre-mRNA splicing. The coordinated actions of TUT1, USB1, and other factors generate a mature 3' end with a 2',3'-cyclic phosphate, which is specifically recognized by the U6 snRNP [1, 6, 8]. Defects in this pathway cause poikiloderma with neutropenia and contribute to splicing-related disorders, highlighting its biomedical importance. Continued research using CRISPR models and advanced RNA methodologies will further elucidate the mechanisms and regulation of this process, potentially revealing new therapeutic targets [2, 6].
References
- 1. Montemayor EJ et al.. 2018. Architecture of the U6 snRNP reveals specific recognition of 3'-end processed U6 snRNA.. Nat Commun 9(1):1749 PMID: 29717126
- 2. Yamashita S et al.. 2023. Mechanism of U6 snRNA oligouridylation by human TUT1.. Nat Commun 14(1):4686 PMID: 37563152
- 4. Li J et al.. 2017. The U6 Biogenesis-Like 1 Plays an Important Role in Maize Kernel and Seedling Development by Affecting the 3' End Processing of U6 snRNA.. Mol Plant 10(3):470-482 PMID: 27825944
- 5. Tazi J et al.. 1993. Mammalian U6 small nuclear RNA undergoes 3' end modifications within the spliceosome.. Mol Cell Biol 13(3):1641-50 PMID: 8441402
- 6. Mroczek S et al.. 2012. C16orf57, a gene mutated in poikiloderma with neutropenia, encodes a putative phosphodiesterase responsible for the U6 snRNA 3' end modification.. Genes Dev 26(17):1911-25 PMID: 22899009
- 7. Yashiro Y et al.. 2018. Function and Regulation of Human Terminal Uridylyltransferases.. Front Genet 9:538 PMID: 30483311
- 8. Gu J et al.. 1997. Formation of 2',3'-cyclic phosphates at the 3' end of human U6 small nuclear RNA in vitro. Identification of 2',3'-cyclic phosphates at the 3' ends of human signal recognition particle and mitochondrial RNA processing RNAs.. J Biol Chem 272(35):21989-93 PMID: 9268336
